Bain Capital Life Sciences Investors, LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$50.11M
Insider Sells Quantity
2
Insider Sells Sum
$173.93M

Insider Activity of Bain Capital Life Sciences Investors, LLC

According to the SEC Form 4 filings, Bain Capital Life Sciences Investors, LLC, being in a position of

  1. 10 percent owner at Heartflow, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 4000000 shares for $115M,
    over all time since 2026-02-04, has bought 0 shares, and sold 4000000 shares for $115M.

Biography of Bain Capital Life Sciences Investors, LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $114,998,3374100

Comparison of Insiders on Amount of Buys and Sells

2026-04-30SaleHeartflow, Inc. Common Stock
HTFL
10 percent owner
948,757
1.0951%
$29.23$27.73M+11.69%
2026-04-29SaleHeartflow, Inc. Common Stock
HTFL
10 percent owner
797,133
0.9245%
$29.37$23.41M+11.89%
2026-04-28SaleHeartflow, Inc. Common Stock
HTFL
10 percent owner
254,110
0.2959%
$30.51$7.75M+7.5%
2026-02-04SaleHeartflow, Inc. Common Stock
HTFL
10 percent owner
2M
2.341%
$28.05$56.1M+4.83%
2025-02-19PurchaseSolid Biosciences Inc.
SLDB
10 percent owner
1M
1.9031%
$4.03$4.03M-16.69%
2025-01-08PurchaseOlema Pharmaceuticals, Inc.
OLMA
10 percent owner
300,000
0.395%
$5.76$1.73M-8.09%
2023-05-25PurchaseAnnexon, Inc.
ANNX
10 percent owner
300,000
0.4125%
$2.13$639,720+64.29%
2021-12-10PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
25,000
0.0858%
$9.65$241,202-70.24%
2021-12-09PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
4,011
0.0145%
$9.84$39,485-69.23%
2021-12-08PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
13,458
0.0484%
$9.62$129,474-68.51%
2021-07-19PurchaseRapid Micro Biosystems, Inc.
RPID
10 percent owner
100,000
0.2804%
$20.00$2M-59.26%
2020-07-28PurchaseAnnexon, Inc.
ANNX
10 percent owner
800,000
2.6558%
$17.00$13.6M+33.07%
2020-02-04PurchaseArcutis Biotherapeutics, Inc.
ARQT
10 percent owner
588,234
1.6079%
$17.00$10M+5.03%
2018-07-24PurchaseReplimune Group, Inc.
REPL
10 percent owner
1M
4.0424%
$15.00$15M-7.15%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.